TCTR20230208005尚未招募4 期
Plasma level of dabigatran comparison between geriatric and young patients with atrial fibrillation
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 100 Years（—）
- 性别
- All
入选标准
- •1. Thai patient who was more than twenty years old and got dabigatran 150 milligrams or 110 milligrams twice daily for non-valvular atrial fibrillation indication.
- •2. Good compliance 100 percents and no change dabigatran at least 7 days.
- •3. The patient signed informed consent; if they can't decide, care given can sign informed consent.
排除标准
- •1. Patient with mechanical valve replacement or moderate to severe mitral stenosis.
- •2. ESRD patient or creatinine clearance less than 30 ml/min.
- •3. Pregnancy or lactation patient.
- •4. Active bleeding
- •5. Platelet count less than 100,000 cell/mm3
研究者
相似试验
招募中
3 期
efficacy and safety of dabigatran(paradxa) in pediatric thromboembolism Referring to Amir Kabir Hospital in Arakchildren-thromboemboli.Embolism and thrombosis of other arteriesIRCT20180711040431N1Arak University of Medical Sciences20
已完成
2 期
?Dabigatran versus warfarin in atrial fibrillation patients post catheter ablatioAtrial Fibrillation.Atrial fibrillation and flutterIRCT2012122311855N1Tehran University of Medical Science100
已完成
2 期
Comparison of Dabigatran and Enoxaparin in prophylaxy of Thromboembolic eventsThromboembolic Disease.198180-189IRCT2013082513828N2?Soicial Security Insurance Office/ Shariati Hospital90
已完成
1 期
Bioavailability of Dabigatran and Amiodarone After Multiple Oral Administrations of Dabigatran Etexilate With or Without Amiodarone as Single Dose in Healthy Male and Female VolunteersHealthyNCT02171026Boehringer Ingelheim24
Unknown
不适用
Real-World Effectiveness and Safety of Dabigatran in Geriatric Patients with Atrial FibrillatioDabigatran was used to prevent ischemic stroke in atrial fibrillation but effectiveness and safety are diferent between geriatric patients and young patients.dabigatran, non-vitamin k antagonist oral anticoagulants, NOAC, direct oral anticoagulant, DOAC, geriatric, elderly, atrial fibrillation, ischemic stroke, bleedingTCTR20221222001Faculty of Pharmacy, Silpakorn University2,134